Phase II Study of P1101 in Early Myelofibrosis
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Ropeginterferon alfa-2b (Primary)
- Indications Myelofibrosis
- Focus Therapeutic Use
- 06 Oct 2016 Planned number of patients changed from 12 to 19.
- 30 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 28 Feb 2015 New trial record